Boston Scientific recall of spinal cord stimulator leads tied to more than 1,000 injuries
Boston Scientific begins to restore shipping after cyberattack
Boston Scientific has begun resuming product shipments from its main distribution centers about a week after a cyberattack, but a full recovery will still take time. The company is working with third-party experts such as CrowdStrike to investigate and emphasized that unauthorized access may have been limited to parts of its internal IT infrastructure.
SNAQ Appoints Former Glooko CEO Russ Johannesson to Its Board of Directors | MedTech Dive
SNAQ, a clinically validated AI nutritionist company focused on diabetes, prediabetes, and metabolic health, announced the appointment of Russ Johannesson to its board of directors. Johannesson previously served as CEO of Glooko, where he built the company into the world's largest cardiometabolic connected care platform, covering 31 countries and supporting over 1.2 million patients. He will assist SNAQ in advancing its strategy for profitable scaling, partnerships, and fundraising.
Proscia Receives New FDA 510(k) Clearance for Concentriq AP-Dx with Predetermined Change Control Plan | MedTech Dive
On August 6, 2026, Proscia announced that its Concentriq AP-Dx digital pathology platform received a new 510(k) clearance from the U.S. FDA, adding compatibility with the Leica Aperio GT 450 DX scanner, cloud deployment, and a Predefined Change Control Plan (PCCP). The PCCP allows Proscia to validate and support additional FDA-cleared scanners, image formats, and displays without requiring additional 510(k) submissions. The platform previously received its initial clearance for the Hamamatsu NanoZoomer S360MD scanner in February 2024 and has obtained CE marking. Proscia achieved the highest customer integration goal support score in the KLAS 2026 Digital Pathology report, serving laboratories managing 12 million cases annually and 16 top pharmaceutical companies.
NovoCure says cyberattack caused patient data exposure
Tumor treatment device manufacturer NovoCure filed with the U.S. Securities and Exchange Commission on Tuesday, disclosing that its information systems experienced unauthorized access in mid-August, leading to the exposure of contact information for some patients, employees, and partner healthcare institutions. The company stated that operations were not affected and does not believe the incident will have a significant impact, but the investigation is still ongoing.
DaVita agrees to pay $15M to settle claims from data breach
DaVita has agreed to pay $15 million to settle a class action lawsuit over a data breach affecting approximately 2.7 million people. The breach originated from an Interlock ransomware attack in April 2025, exposing sensitive patient information. The settlement has received preliminary approval from a Colorado judge, with a final hearing expected next year.
NIPRO Receives FDA 510(k) Clearance, ELISIO™-HX Dialyzer to Enter the U.S. Market
Osaka, Japan — NIPRO CORPORATION announced on July 30, 2026, that its ELISIO-HX dialyzer has received FDA 510(k) clearance from the U.S. (effective July 28, 2026), thereby introducing its HDs therapy to the United States. HDs is an innovative solution developed by NIPRO in the expanded hemodialysis field, aimed at enhancing the removal of middle- and large-molecular-weight toxins using existing dialysis infrastructure and clinical workflows.